Session

PP 05 IBD (Posters)

IMPLICATIONS OF TIOGUANINE DOSING IN IBD PATIENTS WITH A TPMT DEFICIENCY
IMPLICATIONS OF TIOGUANINE DOSING IN IBD PATIENTS WITH A TPMT DEFICIENCY

PROTEIN FINGERPRINT BIOMARKERS OF COLLAGEN REMODELING CAN EVALUATE FIBROGENESIS IN AN IN VITRO COLONIC SCAR-IN-A-JAR MODEL
PROTEIN FINGERPRINT BIOMARKERS OF COLLAGEN REMODELING CAN EVALUATE FIBROGENESIS IN AN IN VITRO COLONIC SCAR-IN-A-JAR MODEL

THE RISK OF MILD, MODERATE AND SEVERE INFECTIONS IN IBD PATIENTS: RESULTS FROM A PROSPECTIVE, MULTICENTRE, OBSERVATIONAL COHORT STUDY - PRIQ
THE RISK OF MILD, MODERATE AND SEVERE INFECTIONS IN IBD PATIENTS: RESULTS FROM A PROSPECTIVE, MULTICENTRE, OBSERVATIONAL COHORT STUDY - PRIQ

A HIGHER RED BLOOD CELL METHOTREXATE POLYGLUTAMATE 3 CONCENTRATION IS ASSOCIATED WITH METHOTREXATE DRUG-SURVIVAL IN PATIENTS WITH CROHN’S DISEASE
A HIGHER RED BLOOD CELL METHOTREXATE POLYGLUTAMATE 3 CONCENTRATION IS ASSOCIATED WITH METHOTREXATE DRUG-SURVIVAL IN PATIENTS WITH CROHN’S DISEASE

PREGNANCY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RETROSPECTIVE DATA FROM A GREEK NATIONAL REGISTRY
PREGNANCY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RETROSPECTIVE DATA FROM A GREEK NATIONAL REGISTRY

LONG-TERM EXPERIENCE WITH USTEKINUMAB IN ULCERATIVE COLITIS PATIENTS: A REAL LIFE MULTICENTRE SPANISH COHORT
LONG-TERM EXPERIENCE WITH USTEKINUMAB IN ULCERATIVE COLITIS PATIENTS: A REAL LIFE MULTICENTRE SPANISH COHORT

MICROBIOME CHARACTERIZATION IN STOOL FROM NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
MICROBIOME CHARACTERIZATION IN STOOL FROM NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE

THE INTERACTION OF GENETIC VARIANTS AND TOBACCO SMOKING IN CROHN’S DISEASE AND ULCERATIVE COLITIS: A GENOME WIDE STUDY
THE INTERACTION OF GENETIC VARIANTS AND TOBACCO SMOKING IN CROHN’S DISEASE AND ULCERATIVE COLITIS: A GENOME WIDE STUDY

THE EFFECT OF COGNITIVE BEHAVIORAL THERAPY IN ADULTS WITH INFLAMMATORY BOWEL DISEASE
THE EFFECT OF COGNITIVE BEHAVIORAL THERAPY IN ADULTS WITH INFLAMMATORY BOWEL DISEASE

IN PATIENTS WITH CROHN'S DISEASE MONITORING OF USTEKINUMAB LEVELS DURING INDUCTION CAN IDENTIFY EARLY INADEQUATE RESPONSE
IN PATIENTS WITH CROHN'S DISEASE MONITORING OF USTEKINUMAB LEVELS DURING INDUCTION CAN IDENTIFY EARLY INADEQUATE RESPONSE

OVEREXPRESSION OF MIR-376A-3P IN CIRCULATING EXOSOMES IN PERIPHERAL BLOOD OF PATIENTS WITH CROHN'S DISEASE
OVEREXPRESSION OF MIR-376A-3P IN CIRCULATING EXOSOMES IN PERIPHERAL BLOOD OF PATIENTS WITH CROHN'S DISEASE

HIGH PROPORTION OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE SHOW SIGNS OF RELEVANT DISEASE ACTIVITY – RESULTS FROM THE GERMAN COHORT OF THE IBD PODCAST STUDY
HIGH PROPORTION OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE SHOW SIGNS OF RELEVANT DISEASE ACTIVITY – RESULTS FROM THE GERMAN COHORT OF THE IBD PODCAST STUDY

PREDICTIVE TRANSCRIPTIONAL SIGNATURES ASSOCIATED TO VEDOLIZUMAB THERAPY RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS
PREDICTIVE TRANSCRIPTIONAL SIGNATURES ASSOCIATED TO VEDOLIZUMAB THERAPY RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS

UNCONTROLLED DEPRESSION AND FEMALE GENDER INCREASES THE RISK OF SEVERE FATIGUE MORE THAN ACTIVITY DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER INFLIXIMAB THERAPY
UNCONTROLLED DEPRESSION AND FEMALE GENDER INCREASES THE RISK OF SEVERE FATIGUE MORE THAN ACTIVITY DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER INFLIXIMAB THERAPY

EFFECTIVENESS AND SAFETY OUTCOMES AFTER LONG-TERM (54 WEEKS) VEDOLIZUMAB THERAPY FOR CROHN'S DISEASE: A PROSPECTIVE, REAL-WORLD OBSERVATIONAL STUDY INCLUDING PATIENT-REPORTED OUTCOMES (POLONEZ II)
EFFECTIVENESS AND SAFETY OUTCOMES AFTER LONG-TERM (54 WEEKS) VEDOLIZUMAB THERAPY FOR CROHN'S DISEASE: A PROSPECTIVE, REAL-WORLD OBSERVATIONAL STUDY INCLUDING PATIENT-REPORTED OUTCOMES (POLONEZ II)

IMPACT OF TWO DIFFERENT TRANSITION PROGRAMS ON TRANSITION READINESS AND QUALITY OF LIFE: A RANDOMISED CONTROLLED TRIAL IN INFLAMMATORY BOWEL DISEASE
IMPACT OF TWO DIFFERENT TRANSITION PROGRAMS ON TRANSITION READINESS AND QUALITY OF LIFE: A RANDOMISED CONTROLLED TRIAL IN INFLAMMATORY BOWEL DISEASE

JAK/STAT PATHWAY AND IL-6 ACTIVITY IN MODERATE TO SEVERE ULCERATIVE COLITIS
JAK/STAT PATHWAY AND IL-6 ACTIVITY IN MODERATE TO SEVERE ULCERATIVE COLITIS

LONG-TERM CULTURING OF HEALTHY- AND ULCERATIVE COLITIS-PATIENT DERIVED COLON ORGANOIDS IS ASSOCIATED WITH DECREASED METHYLATION LEVEL OF LINE-1
LONG-TERM CULTURING OF HEALTHY- AND ULCERATIVE COLITIS-PATIENT DERIVED COLON ORGANOIDS IS ASSOCIATED WITH DECREASED METHYLATION LEVEL OF LINE-1

THE IMPACT OF POINT-OF-CARE INTESTINAL ULTRASOUND IN INFLAMMATORY BOWEL DISEASE PATIENTS
THE IMPACT OF POINT-OF-CARE INTESTINAL ULTRASOUND IN INFLAMMATORY BOWEL DISEASE PATIENTS

SHOTGUN ANALYSIS OF GUT MICROBIOTA WITH BODY COMPOSITION AND LIPID CHARACTERISTICS IN CROHN'S DISEASE
SHOTGUN ANALYSIS OF GUT MICROBIOTA WITH BODY COMPOSITION AND LIPID CHARACTERISTICS IN CROHN'S DISEASE

Item 681 - 700 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34
35
36 37 38 39 40 41 42